-The Hindu The current market prices are essentially over and above the actual cost of production - a difference that could run from 100 per cent to 5,600 per cent, depending upon various therapeutic categories In a liberalised market economy, do we need price controls on drugs? Policymakers and the pharmaceutical industry do not think so. They believe that price controls are an inefficient tool that distorts resource allocation, squeezes revenue, reduces...
More »SEARCH RESULT
The costs of no food security -Ashutosh Varshney
-The Indian Express India is at the point where a low income democracy cannot afford to ignore the hungry Is India's food security ordinance supportable? The debate has been vigorous. It will help to separate the questions of process from those of principle. Whether an ambitious scheme of this magnitude should have been brought in as an executive ordinance or as a new law after parliamentary debate, is basically a procedural question. It...
More »I&B wants to know what you are watching -Abantika Ghosh
-The Indian Express The I&B Ministry is planning to generate real-time data on what the 120 million TV viewing households are watching by putting a chip into the set top boxes (STB). The move comes at a time when dominant television ratings company, TAM Media Research, is facing the heat from the Competition Commission of India (CCI). The move may also raise privacy concerns and invite protests from rights activists but ministry...
More »24 'premium' highway projects hit roadblock, seek bailout -Mihir Mishra
-The Indian Express Two years back, 27 high-density national highway corridors were awarded amid much fanfare to developers who outbid competitors by promising to pay the government a "premium", instead of the general practice of seeking a capital grant from the Centre. Of these projects, all of which were touted as a testimony to renewed investor confidence in the roads sector, 24 sections worth a whopping Rs 34,000 crore and spanning...
More »Monsanto’s climate-resilient crop patent claims rejected -Sanjay Vijayakumar
-The Economic Times CHENNAI: India's patent appeals board has denied Monsanto a patent for a genetically-engineered method of increasing climate resilience in plants. The decision is significant not only for Monsanto's loss of possible exclusivity in an increasingly important segment but also for the interpretation of India's home-grown clauses in patent law - these are unpopular with global companies - for the first time in the case of plants. The Intellectual Property...
More »